附註:Includes bibliographical references and indexes.
Preface -- Epidemiology of Non-Steroidal Anti- Inflammatory Drugs and Cancer -- Pharmacology of COX-2 Inhibitors -- Regulation of COX-2 Expression in Human Cancers -- Cyclooxygenase-2 and Skin Carcinogenesis -- The Role of COX-2 in Breast and Cervical Cancer -- Cyclooxygenase-2: A Target for the Prevention and Treatment of Cancers of the Upper Digestive Tract -- Cyclooxygenase-2 and Colorectal Cancer -- Cyclooxygenase-2 in Lung Cancer -- COX-2 Inhibitors and Other NSAIDs in Bladder and Prostate Cancer.
Therapeutic Potential of Selective Cyclooxygenase- 2 Inhibitors in the Management of Tumor Angiogenesis -- Potential for Combined Modality Therapy of Cyclooxygenase Inhibitors and Radiation -- Non-Steroidal Anti-Inflammatory and Cyclooxygenase- 2- Selective Inhibitors in Clinical Cancer Prevention Trials -- Chemotherapy with Cyclooxygenase-2 Inhibitors in the Treatment of Malignant Disease: Pre- Clinical Rationale and Preliminary Results of Clinical Trials -- Role of COX-Independent Targets of NSAIDs and Related Compounds in Cancer Prevention and Treatment -- Author Index -- Subject Index.
